178 drugs newly listed to NHI reimbursement schedule.

Published: 2004-05-28 06:58:00

Updated: 2004-05-28 06:58:00

MOHW revised the NHI non-reimbursement and the upper limit price list in the 5th Health Insurance Review Council's meeting on May 25 and determined the NHI price approval for 178 products/new drugs and the NHI price reduction for 209 items taking effect from July 1 this year.

209 drugs of redu...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK